Stock Scorer

Neuphoria Therapeutics Inc. (NEUP)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 06-30. Amounts in USD. Every figure as a table ›

Revenue Quarterly

-6M 0 6M 12M 18M Q1 '25: 0 Q2 '25: 662.7K Q3 '25: 15M Q4 '25: -13.3K Q1 '25 Q2 '25 Q3 '25 Q4 '25

Operating Income Quarterly

-10M -5M 0 5M 10M 15M Q1 '24: -5.5M Q2 '24: -4.6M Q3 '24: -2.4M Q4 '24: -5.5M Q1 '25: -3.6M Q2 '25: -3.7M Q3 '25: 12M Q4 '25: -5.8M Q1 '26: -5.7M Q2 '26: -4.1M Q3 '26: -1.2M Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26 Q3 '26

Net Income Quarterly

-12M -8M -4M 0 4M 8M 12M Q1 '24: -5.5M Q2 '24: -4.6M Q3 '24: -2.8M Q4 '24: -2.7M Q1 '25: -804.8K Q2 '25: -1.9M Q3 '25: 11.3M Q1 '26: -9.9M Q2 '26: 1.9M Q3 '26: -505.1K Q2 '24 Q4 '24 Q2 '25 Q1 '26 Q3 '26

Operating Cash Flow Quarterly

-8M -4M 0 4M 8M 12M Q1 '24: -4.4M Q2 '24: -3.9M Q3 '24: -3.3M Q4 '24: -3M Q1 '25: -4.4M Q2 '25: -3.4M Q3 '25: 11.5M Q4 '25: -3.6M Q1 '26: -3.8M Q2 '26: -6.4M Q3 '26: -3.3M Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26 Q3 '26

Shares Outstanding Quarterly

0 600M 1.2B 1.8B Q1 '24: 1.5B Q2 '24: 857.3K Q3 '24: 981K Q1 '25: 1.3M Q2 '25: 1.6M Q3 '25: 1.7M Q1 '26: 2.2M Q2 '26: 4.5M Q3 '26: 5.4M Q1 '24 Q3 '24 Q2 '25 Q1 '26 Q3 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-15.00 -10.00 -5.00 0.00 5.00 10.00 15.00 Q4 '24: -11.56 Q1 '25: -12.18 Q2 '25: -8.66 Q3 '25: 0.72 Q4 '25: -0.23 Q1 '26: -4.02 Q2 '26: -3.00 Q3 '26: -9.64 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26 Q3 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.

Not drawn for NEUP: Gross Profit, Cost of Revenue, Free Cash Flow. Nothing in this filer's XBRL supports them for the periods asked for. That is a gap in the filing, not a zero, and drawing a flat line would be an invention.